SLN124
SLN124 is a GalNAc-conjugated siRNA therapeutic targeting TMPRSS6. It is designed to modulate iron homeostasis by inhibiting Tmprss6 expression, showing potential for research in iron overload disorders like β-thalassemia in both in vitro and in vivo models.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Yyj3746-500gEcoli 500 µg (E. coli)
Recombinant Mycobacterium Ulcerans MUL_2060 Protein (aa 1-122)
Sign In for Pricing
View Details 
AAP49638-100UG 100 µg
C19orf15 Peptide - C-terminal region (AAP49638)
Sign In for Pricing
View Details 
